Results 11 to 20 of about 48,888 (227)
Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and
Laura, Carone +5 more
+5 more sources
Furosemide Use in Chronic Kidney Disease Patients [PDF]
Chronic kidney disease is defined as kidney disease occurring for more than three months and is characterized by a decreasing glomerular filtration rate, reaching below 60 mL/min/1.73 m2 .
Hasmono, Didik +3 more
core +1 more source
Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2. [PDF]
11Beta-hydroxsteroid dehydrogenase 2 (11beta-OHSD2) protects the nonselective renal mineralocorticoid receptor from the endogenous glucocorticoid cortisol. Thus, drugs inhibiting 11beta-OHSD2 might enhance urinary loss of potassium.
Fuster, D. +13 more
core +2 more sources
Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites [PDF]
Torasemide is a new loop diuretic with a longer half-life and longer action than furosemide in healthy subjects. In order to evaluate the pharmacodynamic effects, single oral doses of furosemide (80 mg) and torasemide (20 mg), which were equipotent in ...
Paumgartner, Gustav +4 more
core +1 more source
Potentiometric determination of furosemide
A simple method is presented for the potentiometric determination of small quantities of furosemide in a pure state and in pharmaceutical formulations, using 0.1 mol l-1 chloramine-T as titrant.
Nikolić, Kosta, Medenica, Mirjana
core +7 more sources
Furosemide stimulates renin expression in the kidneys of salt-supplemented rats [PDF]
This study was conducted to obtain information about a possible influence of salt transport by the thick ascending limb of Henle (TALH) and the macula densa on the expression of renin in the kidney.
Eckardt, K. U. +6 more
core +1 more source
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman +4 more
wiley +1 more source
Acute generalized exanthematous pustulosis provoked by furosemide [PDF]
Introduction. Acute generalized exanthematous pustulosis (AGEP) is a skin disease characterized by the sudden appearance of generalized pustules, accompanied by elevated body temperature and neutrophilia. Objective.
Aleksandra Wilkowska +4 more
core +1 more source
Medical treatment of ascites in cirrhosis [PDF]
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfort, impaired cardiovascular or respiratory function and potential for infection. Treatment of ‘simple’ ascites (moderate fluid accumulation, serum albumin
Gerbes, Alexander L.
core +1 more source
Furosemide is commonly prescribed in critically ill patients to increase the urine output and prevent fluid overload (FO) and acute kidney injury (AKI), but not supported by conclusive evidence.
Xiaomei Dai +7 more
doaj +1 more source

